Literature DB >> 25966615

Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.

C S Janota1, D Brites2, C A Lemere3, M A Brito4.   

Abstract

Vascular and glial involvement in the development of neurodegenerative disorders, such as Alzheimer's disease (AD), and age-related brain vulnerabilities have been suggested. Therefore, we sought to: (i) investigate which vascular and glial events are evident in ageing and/or AD, (ii) to establish the temporal evolution of vascular and glial changes in AD-like and wild-type (WT) mice and (iii) to relate them to amyloid-β (Aβ) peptide accumulation. We examined immunohistochemically hippocampi and cortex from APP/PS1dE9 and WT C57BL/6 mice along ageing and disease progression (young-adulthood, middle- and old-age). Ageing resulted in the increase in receptor for advanced glycation endproducts expression, as well as the entrance of thrombin and albumin in hippocampal parenchyma. In contrast, the loss of platelet-derived growth factor receptor-β (PDGFR-β) positive cells, in both regions, was only related to AD pathogenesis. Hypovascularization was affected by both ageing and AD in the hippocampus, but resulted from the interaction between both factors in the cortex. Astrogliosis was a result of AD in hippocampus and of both factors in cortex, while microgliosis was associated with fibrillar amyloid plaques in AD-like mice and with the interaction between both factors in each of the studied regions. In sum, these data show that senile plaques precede vascular and glial alterations only in hippocampus, whereas in cortex, vascular and glial alterations, namely the loss of PDGFR-β-positive cells and astrogliosis, accompanied the first senile plaques. Hence, this study points to vascular and glial events that co-exist in AD pathogenesis and age-related brain vulnerabilities.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer׳s disease; Blood-brain barrier disruption; Glial activation; Microvasculature; Pericytes; Receptor for advanced glycation endproducts

Mesh:

Substances:

Year:  2015        PMID: 25966615      PMCID: PMC4549169          DOI: 10.1016/j.brainres.2015.04.056

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  61 in total

1.  Memory impairment in transgenic Alzheimer mice requires cellular prion protein.

Authors:  David A Gimbel; Haakon B Nygaard; Erin E Coffey; Erik C Gunther; Juha Laurén; Zachary A Gimbel; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia.

Authors:  Rufus O Akinyemi; Elizabeta B Mukaetova-Ladinska; Johannes Attems; Masafumi Ihara; Raj N Kalaria
Journal:  Curr Alzheimer Res       Date:  2013-07       Impact factor: 3.498

Review 3.  What causes alzheimer's disease?

Authors:  R A Armstrong
Journal:  Folia Neuropathol       Date:  2013       Impact factor: 2.038

4.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls.

Authors:  Samir Kumar-Singh; Daniel Pirici; Eileen McGowan; Sally Serneels; Chantal Ceuterick; John Hardy; Karen Duff; Dennis Dickson; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 5.  Cerebral microvascular pathology in aging and Alzheimer's disease.

Authors:  E Farkas; P G Luiten
Journal:  Prog Neurobiol       Date:  2001-08       Impact factor: 11.685

Review 6.  Neuropathological alterations in Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew P Frosch; Eliezer Masliah; Bradley T Hyman
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

7.  LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

Authors:  Rashid Deane; Zhenhua Wu; Abhay Sagare; Judianne Davis; Shi Du Yan; Katie Hamm; Feng Xu; Margaret Parisi; Barbra LaRue; Hong Wei Hu; Patricia Spijkers; Huang Guo; Xiaomei Song; Peter J Lenting; William E Van Nostrand; Berislav V Zlokovic
Journal:  Neuron       Date:  2004-08-05       Impact factor: 17.173

8.  Increased blood-brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model.

Authors:  Shuko Takeda; Naoyuki Sato; Kazuko Ikimura; Hirohito Nishino; Hiromi Rakugi; Ryuichi Morishita
Journal:  Neurobiol Aging       Date:  2013-04-02       Impact factor: 4.673

9.  Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

Authors:  Miles C Miller; Rosemarie Tavares; Conrad E Johanson; Virginia Hovanesian; John E Donahue; Liliana Gonzalez; Gerald D Silverberg; Edward G Stopa
Journal:  Brain Res       Date:  2008-07-14       Impact factor: 3.252

10.  Blood-brain barrier breakdown in the aging human hippocampus.

Authors:  Axel Montagne; Samuel R Barnes; Melanie D Sweeney; Matthew R Halliday; Abhay P Sagare; Zhen Zhao; Arthur W Toga; Russell E Jacobs; Collin Y Liu; Lilyana Amezcua; Michael G Harrington; Helena C Chui; Meng Law; Berislav V Zlokovic
Journal:  Neuron       Date:  2015-01-21       Impact factor: 17.173

View more
  19 in total

1.  Astrocytic changes with aging and Alzheimer's disease-type pathology in chimpanzees.

Authors:  Emily L Munger; Melissa K Edler; William D Hopkins; John J Ely; Joseph M Erwin; Daniel P Perl; Elliott J Mufson; Patrick R Hof; Chet C Sherwood; Mary Ann Raghanti
Journal:  J Comp Neurol       Date:  2019-01-07       Impact factor: 3.215

Review 2.  Heterogeneity of the blood-brain barrier.

Authors:  Imola Wilhelm; Ádám Nyúl-Tóth; Maria Suciu; Anca Hermenean; István A Krizbai
Journal:  Tissue Barriers       Date:  2016-01-28

Review 3.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

4.  Induction of ICAM1 in Brain Vessels is Implicated in an Early AD Pathogenesis by Modulating Neprilysin.

Authors:  Degeree Otgongerel; Hyeon-Ju Lee; Sangmee Ahn Jo
Journal:  Neuromolecular Med       Date:  2022-08-10       Impact factor: 4.103

5.  Aging Exacerbates Neuroinflammatory Outcomes Induced by Acute Ozone Exposure.

Authors:  Christina R Tyler; Shahani Noor; Tamara L Young; Valeria Rivero; Bethany Sanchez; Selita Lucas; Kevin K Caldwell; Erin D Milligan; Matthew J Campen
Journal:  Toxicol Sci       Date:  2018-05-01       Impact factor: 4.849

Review 6.  Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: A translational perspective.

Authors:  Eduardo Candelario-Jalil; Surojit Paul
Journal:  Exp Neurol       Date:  2020-10-07       Impact factor: 5.330

Review 7.  Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease.

Authors:  Oliver Bracko; Jean C Cruz Hernández; Laibaik Park; Nozomi Nishimura; Chris B Schaffer
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

8.  Age-associated changes in the blood-brain barrier: comparative studies in human and mouse.

Authors:  E F Goodall; C Wang; J E Simpson; D J Baker; D R Drew; P R Heath; M J Saffrey; I A Romero; S B Wharton
Journal:  Neuropathol Appl Neurobiol       Date:  2017-05-29       Impact factor: 8.090

9.  Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice.

Authors:  Ceren Ozek; Richard C Krolewski; Sean M Buchanan; Lee L Rubin
Journal:  Sci Rep       Date:  2018-11-23       Impact factor: 4.379

10.  Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.

Authors:  Heather Buchanan; Murray Mackay; Kerri Palmer; Karolína Tothová; Miroslava Katsur; Bettina Platt; David J Koss
Journal:  Mol Neurobiol       Date:  2020-06-08       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.